New York, NY -- (SBWIRE) -- 01/24/2014 -- King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Today We bring special trend analysis of following stocks: Oncolytics Biotech, Inc. (USA)(NASDAQ:ONCY), IsoRay, Inc. (NYSEMKT:ISR), Ascent Solar Technologies, Inc. (NASDAQ:ASTI), Atossa Genetics Inc (NASDAQ:ATOS)
PLUS you’ll get KingPennyStock’s Pro Trading Rules Mini E-book absolutely FREE! Claim Your Copy
Oncolytics Biotech, Inc. (USA)(NASDAQ:ONCY) percentage change surged +6.29% to close at $1.86 with the total traded volume of 2.17 million shares, and average volume of 545,920.00 shares. The 52 week range of the stock remained $1.45 - $4.93, while its day lowest price was $1.72 and it hit its day highest price at $1.90. Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancers.
For How Long ONCY will Fight for Profitability? Read This Trend Analysis report
IsoRay, Inc. (NYSEMKT:ISR) opened its shares at the price of $0.80 for the day. Its closing price was $0.850 after gaining +6.25% for the day. The company traded with the total volume of 1.51 million shares, while its average trading volume remained 1.49 million shares. The beta of ISR stands at 0.27. IsoRay, Inc develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases primarily in the United States.
For How Long ISR’s Gloss will Attract Investors? Find out via this report
Ascent Solar Technologies, Inc. (NASDAQ:ASTI) started its trading session with the price of $0.69 and closed at $0.710 by scoring +5.67%. ASTI’s stocks traded with total volume of 1.26 million shares, while the average trading volume remained 493,629.00 shares. The beta of ASTI stands at 2.49. Day range of the stock was $0.65 -$0.72. Ascent Solar Technologies, Inc., a development stage company, designs and manufactures photovoltaic integrated consumer electronics; and portable power applications for commercial and military users.
Will ASTI Continue To Move Higher? Find Out Here
Atossa Genetics Inc (NASDAQ:ATOS) ended its day with the gain of +5.96% and closed at the price of $3.20 after opening at $2.90. Stock traded during its last trading session with the total volume of 3.11 million shares, as compared to its average volume of 398,490.00 shares. Atossa Genetics, Inc. operates as a healthcare company that focuses on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer in the United States.
Why Should Investors Buy ATOS After The Recent Gain? Just Go Here and Find Out
About King Penny Stocks
King Penny Stocks provides up to the minute dissemination of news while reporting on stocks that are actively traded in the small cap arena whether trading on the Nasdaq small caps, AMEX or the OTC markets. Since performance is key in our industry, it’s no wonder why our ground breaking alerts on active stocks have brought us to the forefront of this industry. Our due diligence on trend analysis has caught the attention of the very best chart technicians in the business.
King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Get detailed breakdowns of major trends impacting the markets.
Our newsletter, Press Release and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.
An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research. This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation.
Read our Full Disclaimer at: http://kingpennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)